myelodysplastic syndrome

FDA probes blood cancer risk from bluebird's gene therapy, weighs regulatory action
Medpage Today
Wed, 11/27/24 - 09:59 pm
Bluebird Bio
Skysona
FDA
myelodysplastic syndrome
AML
cALD
FDA staff raises concerns on Geron's blood disorder drug
Reuters
Tue, 03/12/24 - 11:06 am
Geron
FDA
imetelstat
myelodysplastic syndrome
Patient death spurs trial halt for Magenta Therapeutics
Endpoints
Thu, 01/26/23 - 10:38 am
Magenta Therapeutics
MGTA-117
clinical trials
patient deaths
AML
myelodysplastic syndrome
Why The Magenta Therapeutics (MGTA) Stock Plummeted Over 50%
Pulse 2.0
Wed, 12/21/22 - 11:27 am
Magenta Therapeutics
clinical trials
MGTA-117
AML
myelodysplastic syndrome
With positive trial results, Bristol Myers looks to widen use of blood disease drug
BioPharma Dive
Mon, 10/31/22 - 04:13 pm
Bristol Myers Squibb
Reblozyl
myelodysplastic syndrome
I-Mab reports positive data from Phase II myelodysplastic syndrome trial
Clinical Trials Arena
Mon, 09/12/22 - 10:45 am
I-Mab
clinical trials
lemzoparlimab
myelodysplastic syndrome
EHA 2021 – Curis’s renaissance continues
EP Vantage
Fri, 05/14/21 - 10:43 am
Curis
CA-4948
EHA
myelodysplastic syndrome
acute myelogenous leukemia
clinical trials
Onconova reports PhIII flop, putting high-risk MDS program on the chopping block
Endpoints
Mon, 08/24/20 - 10:32 am
Onconova
clinical trials
Rigosertib
myelodysplastic syndrome
Takeda gets FDA breakthrough therapy status for pevonedistat to treat higher-risk HR-MDS
Pharmaceutical Business Review
Fri, 07/31/20 - 10:42 am
Takeda Pharmaceuticals
breakthrough status
FDA
pevonedistat
myelodysplastic syndrome
This Cancer Drug Is Driving Forty Seven's Stock Higher
Motley Fool
Mon, 01/27/20 - 10:56 pm
Forty Seven
magrolimab
clinical trials
myelodysplastic syndrome
Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints
BioSpace
Fri, 06/7/19 - 10:07 pm
Astex
Otsuka
clinical trials
ASTX727
myelodysplastic syndrome
CMML
Celgene and Acceleron Submit BLA for Luspatercept
CP Wire
Fri, 04/5/19 - 11:44 am
Celgene
Acceleron
luspatercept
myelodysplastic syndrome
beta thalassemia
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia
CP Wire
Thu, 09/27/18 - 10:09 am
CytoSen
CSTD002-NK
acute myeloid leukemia
myelodysplastic syndrome
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia
Thu, 09/27/18 - 09:57 am
CytoSen
CSTD002-NK
acute myeloid leukemia
myelodysplastic syndrome
Acceleron blood disease drug hits goal in pivotal clinical trial
Stat
Thu, 06/28/18 - 07:10 pm
Acceleron
Celgene
luspatercept
clinical trials
myelodysplastic syndrome
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
CP Wire
Wed, 05/2/18 - 10:52 am
Aptevo
FDA
APVO436
AML
myelodysplastic syndrome
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
Wed, 05/2/18 - 10:53 am
Aptevo
APVO436
acute myeloid leukemia
myelodysplastic syndrome
Geron Collaborates with J&J for Imetelstat
Yahoo/Zacks
Sat, 11/15/14 - 09:42 am
Geron
JNJ
imetelstat
myelofibrosis
acute myelogenous leukemia
myelodysplastic syndrome
leukemia
Sunesis says encouraged by trial of Qinprezo
The Fly on the Wall
Mon, 06/2/14 - 11:07 am
Qinprexo
Sunesis
ASCO
acute myeloid leukemia
myelodysplastic syndrome
Can This Celgene Drug Defy the Patent Cliff?
Motley Fool
Tue, 02/12/13 - 10:57 am
patents
Celgene
myelodysplastic syndrome
Vidaza

Pages